| S. No. | Compounds | Binding affinities (kcal/mol | H-bonds | Residual interactions | Hydrophobic (pi-cation) and others | Van der Waals |
| 1 | L 1 C10H12N6O2 | −8.2 | Lys-460, Arg-458:O, Arg-458:CD, DG-9, DT-10, DA-11, DC-12, and DA-13 | T-shaped-DA-13 Alkyl-Arg-458 | Gly-459, Asn-475, Glu-477, Ile-461, and DC-14 | 2 | L 2 C12H15N3O3 | −8.0 | Ser-1084: HG, Ser-1084: OG, Arg-458:CD, Arg-458:O, Arg-1122, Glu-477, DA13:N3, and DA-13: O4′ DT-8 | Pi-cation-DT-8 electrostatic-pi-cation-DG-9 Pi-sigma-DT-8, pi-pi -DG-9, Pi-pi-DA-13(Dist. 4.12239 Å) Pi-pi -DA-13(Dist. 3.67512 Å) Alkyl-Arg-458, pi-Alkyl-DA-13(Dist. 5.19252 Å), and pi-Alkyl-DA-13(Dist. 4.36677 Å) | Gly-1082 and DG-12 | 3 | [Cu(L1) (L2)] C22H25N9O5Cu | −8.4 | Ser-438:HN, Ser-438: OG, Asp-1083 (Dist. 2.81399), Asp-1083 (Dist. 3.3489), DG-9: O6, and DG-9: N7 | Pi-sigma-Ala-1120, pi-Sigma-Met-1121, Alkyl-Ala-1120, Alkyl-Met-1121, Alkyl-Arg-1122, and pi-Alkyl-Ala-1120 | Tyr-1087, Ser-1084, Glu-1088, Ala-1118, Ala-1119, Gly-1117, Met-1075, and Phe-1123, Asp-437 | Trimethoprim C14H18N4O3 | −7.9 | Arg-458: DT-8,HH11, Arg-458: DG-9, CD, and DC-12 | Pi-pi-DT-8, pi-pi -DG-9, pi-pi T-Shaped-DA-13, Alkyl-Arg-458, and pi-Alkyl-Arg-458 Pi-Alkyl-DA-13 | Phe-1123, Gly-459, Asp-437, and DT-10 |
|
|